Irinotecan, temozolomide, and dinutuximab with GM-CSF in children with refractory or relapsed neuroblastoma: A report from the children’s Oncology group

Rajen Mody, Alice L. Yu, Arlene Naranjo, Fan F. Zhang, Wendy B. London, Barry L. Shulkin, Marguerite T. Parisi, Sabah E.Noor Servaes, Mitchell B. Diccianni, Jacquelyn A. Hank, Mildred Felder, Jennifer Birstler, Paul M. Sondel, Shahab Asgharzadeh, Julia Glade-Bender, Howard Katzenstein, John M. Maris, Julie R. Park, Rochelle Bagatell

Research output: Contribution to journalArticlepeer-review

105 Scopus citations

Fingerprint

Dive into the research topics of 'Irinotecan, temozolomide, and dinutuximab with GM-CSF in children with refractory or relapsed neuroblastoma: A report from the children’s Oncology group'. Together they form a unique fingerprint.

Medicine & Life Sciences